Asymchem Laboratories (Tianjin) Co., Ltd. (SHE:002821)

China flag China · Delayed Price · Currency is CNY
129.49
+11.77 (10.00%)
Apr 28, 2026, 3:04 PM CST
73.88%
Market Cap 45.71B
Revenue (ttm) 6.93B
Net Income (ttm) 1.11B
Shares Out 359.72M
EPS (ttm) 3.11
PE Ratio 41.66
Forward PE 31.92
Dividend 1.30 (1.10%)
Ex-Dividend Date Jun 26, 2025
Volume 9,880,656
Average Volume 12,620,027
Open 111.50
Previous Close 117.72
Day's Range 111.50 - 129.49
52-Week Range 72.06 - 129.80
Beta 0.07
RSI 71.12
Earnings Date Mar 30, 2026

About SHE:002821

Asymchem Laboratories (Tianjin) Co., Ltd. provides contract development and manufacturing organization (CDMO) solutions in Mainland China and internationally. It is involved in small molecule CDMO services for projects covering multiple major disease treatment areas, such as oncology, antiviral, anti-infective, cardiovascular, and diabetes; chemical macromolecule CDMO; biomacromolecule CDMO, including antibody-peptide conjugates; formulation CDMO; clinical CRO; synthetic biology and new technology output business. The company also engages in ke... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1998
Employees 10,617
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002821
Full Company Profile

Financial Performance

In 2025, SHE:002821's revenue was 6.67 billion, an increase of 14.91% compared to the previous year's 5.80 billion. Earnings were 1.13 billion, an increase of 19.35%.

Financial Statements

News

There is no news available yet.